The U.S. retail clinics market size is evaluated at USD 3.86 billion in 2024, grew to USD 4.18 billion in 2025 and is projected to reach around USD 8.45 billion by 2034. The market is expanding at a CAGR of 8.15% between 2024 and 2034.
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: U.S. Retail Clinics Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. U.S. Retail Clinics Market, by Ownership, 2024-2034
8.1.1 Retail-Owned Retail Clinics
8.1.1.1. Market Revenue and Forecast (2021-2034)
8.1.2. Hospital-Owned Retail Clinics
8.1.2.1. Market Revenue and Forecast (2021-2034)
9.1. U.S. Retail Clinics Market, by Application, 2024-2034
9.1.1. Point-Of-Care Diagnostics
9.1.1.1. Market Revenue and Forecast (2021-2034)
9.1.2. Clinical Chemistry and Immunoassays
9.1.2.1. Market Revenue and Forecast (2021-2034)
9.1.3. Vaccinations
9.1.3.1. Market Revenue and Forecast (2021-2034)
9.1.4. Others
9.1.4.1. Market Revenue and Forecast (2021-2034)
10.1. U.S. Retail Clinics Market, by Distribution Channel, 2024-2034
10.1.1. Retail Pharmacy Settings
10.1.1.1. Market Revenue and Forecast (2021-2034)
10.1.2. Drug Stores
10.1.2.1. Market Revenue and Forecast (2021-2034)
10.1.3. Grocery Chains and Big Box Stores
10.1.3.1. Market Revenue and Forecast (2021-2034)
11.1. U.S.
11.1.1. Market Revenue and Forecast, by Ownership (2021-2034)
11.1.2. Market Revenue and Forecast, by Application (2021-2034)
11.1.3. Market Revenue and Forecast, by Distribution Channel (2021-2034)
12.1. CVS Health
12.1.1. Company Overview
12.1.2. Product Offerings
12.1.3. Financial Performance
12.1.4. Recent Initiatives
12.2. Kroger Health
12.2.1. Company Overview
12.2.2. Product Offerings
12.2.3. Financial Performance
12.2.4. Recent Initiatives
12.3. Walgreens
12.3.1. Company Overview
12.3.2. Product Offerings
12.3.3. Financial Performance
12.3.4. Recent Initiatives
12.4. Advocate Health Care
12.4.1. Company Overview
12.4.2. Product Offerings
12.4.3. Financial Performance
12.4.4. Recent Initiatives
12.5. Kaiser Foundation Health Plan, Inc.
12.5.1. Company Overview
12.5.2. Product Offerings
12.5.3. Financial Performance
12.5.4. Recent Initiatives
12.6. Walmart
12.6.1. Company Overview
12.6.2. Product Offerings
12.6.3. Financial Performance
12.6.4. Recent Initiatives
12.7. Bellin Health Systems
12.7.1. Company Overview
12.7.2. Product Offerings
12.7.3. Financial Performance
12.7.4. Recent Initiatives
12.8. Geisinger Health
12.8.1. Company Overview
12.8.2. Product Offerings
12.8.3. Financial Performance
12.8.4. Recent Initiatives
12.9. Target
12.9.1. Company Overview
12.9.2. Product Offerings
12.9.3. Financial Performance
12.9.4. Recent Initiatives
13.1. Primary Research
13.2. Secondary Research
13.3. Assumptions
14.1. About Us
14.2. Glossary of Terms
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
Report Description
Get a Sample